Sign in

CIK 0001429260

  • Non-accelerated filer
  • Smaller reporting company

Fortress Biotech, Inc.

Sign in to watch
Ticker
FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205157386
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
Former names
Fortress Biotech, Inc., CORONADO BIOSCIENCES INC

Securities

  • FBIO Common Stock Nasdaq
  • FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
  1. 4 Grant or award Director acquired 100,000 shares (grant or award)
  2. 4 Open-market sale Chief Financial Officer sold 20,370 shares at $1.29 ($26,277)
  3. 4 Open-market sale SVP, BIOLOGICS OPERATIONS sold 12,000 shares at $3.55 ($42,600)
  4. 4 Open-market sale SVP, BIOLOGICS OPERATIONS sold 44,593 shares at an average $3.58 ($159,709)
  5. 4 Open-market buy PRESIDENT, CEO bought 40,000 shares at $25.00 ($1,000,000)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Returned to the company Director returned 13,333 shares (to the company)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award 10% owner acquired 1,132,653 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Insider Changes in Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Exec. VC - Strategic Dev. acquired 552,698 shares (grant or award)
  16. 4 Open-market buy President and CEO bought 731 shares at $2.03 ($1,484)
  17. 4 Grant or award Director acquired 100,000 shares (grant or award)
  18. 4 Grant or award Director acquired 100,000 shares (grant or award)
  19. 4 Grant or award Director acquired 100,000 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 8 of 15 · 289 filings